Literature DB >> 17256749

Nonalcoholic fatty liver sensitizes rats to carbon tetrachloride hepatotoxicity.

Shashikiran Donthamsetty1, Vishakha S Bhave, Mayurranjan S Mitra, John R Latendresse, Harihara M Mehendale.   

Abstract

UNLABELLED: This study tested whether hepatic steatosis sensitizes liver to toxicant-induced injury and investigated the potential mechanisms of hepatotoxic sensitivity. Male Sprague-Dawley rats were fed a methionine- and choline-deficient diet for 31 days to induce steatosis. On the 32nd day, administration of a nonlethal dose of CCl4 (2 mL/kg, intraperitoneally) yielded 70% mortality in steatotic rats 12-72 hours after CCl4 administration, whereas all nonsteatotic rats survived. Neither CYP2E1 levels nor covalent binding of [14C] CCl4-derived radio-label differed between the groups, suggesting that increased bioactivation is not the mechanism for this amplified toxicity. Cell division and tissue repair, assessed by [3H]thymidine incorporation and proliferative cell nuclear antigen assay, were inhibited in the steatotic livers after CCl4 administration and led to progressive expansion of liver injury culminating in mortality. The hypothesis that fatty hepatocytes undergo cell cycle arrest due to (1) an inability to replenish ATP due to overexpressed uncoupling protein-2 (UCP-2) or (2) induction of growth inhibitor p21 leading to G1/S phase arrest was tested. Steatotic livers showed 10-fold lower ATP levels due to upregulated UCP-2 throughout the time course after CCl4 administration, leading to sustained inhibition of cell division. Western blot analysis revealed an up-regulation of p21 due to overexpression of TGF beta1 and p53 and down-regulation of transcription factor Foxm 1b in steatotic livers leading to lower phosphorylated retinoblastoma protein. Thus, fatty hepatocytes fail to undergo compensatory cell division, rendering the liver susceptible to progression of liver injury.
CONCLUSION: Impaired tissue repair sensitizes the steatotic livers to hepatotoxicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17256749     DOI: 10.1002/hep.21530

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  21 in total

1.  Impact of Nonalcoholic Fatty Liver Disease on Toxicokinetics of Tetrachloroethylene in Mice.

Authors:  Joseph A Cichocki; Shinji Furuya; Kranti Konganti; Yu-Syuan Luo; Thomas J McDonald; Yasuhiro Iwata; Weihsueh A Chiu; David W Threadgill; Igor P Pogribny; Ivan Rusyn
Journal:  J Pharmacol Exp Ther       Date:  2017-02-01       Impact factor: 4.030

2.  P2X7 receptor-NADPH oxidase axis mediates protein radical formation and Kupffer cell activation in carbon tetrachloride-mediated steatohepatitis in obese mice.

Authors:  Saurabh Chatterjee; Ritu Rana; Jean Corbett; Maria B Kadiiska; Joyce Goldstein; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2012-02-15       Impact factor: 7.376

3.  Nonalcoholic fatty liver disease in a district general hospital: clinical presentation and risk factors.

Authors:  Wing-Kin Syn; Peter Nightingale; Jeffrey M Bateman
Journal:  Hepatol Int       Date:  2008-02-28       Impact factor: 6.047

4.  Methionine deficiency and hepatic injury in a dietary steatohepatitis model.

Authors:  Helieh S Oz; Theresa S Chen; Manuela Neuman
Journal:  Dig Dis Sci       Date:  2007-08-21       Impact factor: 3.199

5.  Nonalcoholic Fatty Liver Disease Is a Susceptibility Factor for Perchloroethylene-Induced Liver Effects in Mice.

Authors:  Joseph A Cichocki; Shinji Furuya; Yu-Syuan Luo; Yasuhiro Iwata; Kranti Konganti; Weihsueh A Chiu; David W Threadgill; Igor P Pogribny; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2017-09-01       Impact factor: 4.849

6.  The protective role of Per2 against carbon tetrachloride-induced hepatotoxicity.

Authors:  Peng Chen; Chunying Li; Wenqaing Pang; Yue Zhao; Wei Dong; Shiming Wang; Jianfa Zhang
Journal:  Am J Pathol       Date:  2008-12-04       Impact factor: 4.307

7.  A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophen.

Authors:  Anaïs Michaut; Dounia Le Guillou; Caroline Moreau; Simon Bucher; Mitchell R McGill; Sophie Martinais; Thomas Gicquel; Isabelle Morel; Marie-Anne Robin; Hartmut Jaeschke; Bernard Fromenty
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-29       Impact factor: 4.219

Review 8.  Biochemical mechanisms in drug-induced liver injury: certainties and doubts.

Authors:  Ignazio Grattagliano; Leonilde Bonfrate; Catia V Diogo; Helen H Wang; David Q H Wang; Piero Portincasa
Journal:  World J Gastroenterol       Date:  2009-10-21       Impact factor: 5.742

9.  Modulation of Tetrachloroethylene-Associated Kidney Effects by Nonalcoholic Fatty Liver or Steatohepatitis in Male C57BL/6J Mice.

Authors:  Joseph A Cichocki; Yu-Syuan Luo; Shinji Furuya; Abhishek Venkatratnam; Kranti Konganti; Weihsueh A Chiu; David W Threadgill; Igor P Pogribny; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2019-01-01       Impact factor: 4.849

Review 10.  Current concepts of mechanisms in drug-induced hepatotoxicity.

Authors:  Stefan Russmann; Gerd A Kullak-Ublick; Ignazio Grattagliano
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.